Carlos A. David, MD, serves as director of Cerebrovascular and Skull Base Surgery at Lahey Hospital & Medical Center and assistant professor in the Department of Neurosurgery at Tufts University School of Medicine. He was born in Pittsburgh, Pennsylvania and grew up in South Florida. Dr. David performed research on reperfusion injury to the brain during temporary clipping for aneurysm surgery and received the 2nd prize for basic science research at the 1994 Southern Neurosurgical Society Meeting during his time as a resident. After completing his neurosurgery residency, Dr. David pursued further training in complex Cerebrovascular and Skull Base Tumor Surgery, serving as Fellow at the Barrow Neurological Institute under the auspices of Dr. Robert Spetzler. He completed his fellowship in 1998 at which time he began his academic career at the University of Missouri School of Medicine. He served as Assistant Professor of Neurosurgery, the Director of Neurosurgery at the Harry S. Truman VA Hospital, and Director of the Neurosurgical ICU at the University of Missouri Hospital. Dr. David is a member of the Congress of Neurological Surgeons, American Association of Neurological Surgeons, North American Skull Base Society, Joint AANS/CNS Cerebrovascular Section, Neurosurgical Society of America, and the Society of University Neurosurgeons. He is a Member at Large for the Joint AANS/CNS Cerebrovascular Section Executive Board, and serves on the CNS Fellowship Committee, the Annual Meeting Committee of the North American Skull Base Society, and the Executive Board of the New England Neurosurgical Society. He is faculty for the AANS Oral Board Review Course, the St. Louis Practical Anatomy course on “Microsurgery of Aneurysms”, and the North American Skull Base Society Annual “Skull Base Approaches” course. He currently serves on the medical advisory board for the Brain Aneurysm Foundation. He has authored over 50 scientific articles and book chapters, and has also served as guest editor of Operative Techniques in Neurosurgery: Management of Jugular Foramen Tumors. In addition, Dr. David has given over 60 presentations at national and international scientific meetings.
A Prospective, Multi-center Trial of NovoTTF-100A together with Temozolomide compared to Temozolomide alone in patients with newly diagnosed GBM.